Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 for Secondary Prophylaxis of Hepatic Encephalopathy
NCT01110447Phase 3Completed
- Sponsor
- CD Pharma Group
- Start
- Apr 2010
- Primary completion
- Mar 2013
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
A Phase 3 trial of VSL#3 in hepatic encephalopathy (HE), sponsored by CD Pharma Group. Started Apr 2010; status: completed.
02
Drugs
VSL#3
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01110447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01110447.